These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17121432)

  • 21. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM; Shackleford GM
    Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
    Strumane K; Rygiel T; van der Valk M; Collard JG
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
    Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
    Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteotypic classification of spontaneous and transgenic mammary neoplasms.
    Mikaelian I; Blades N; Churchill GA; Fancher K; Knowles BB; Eppig JT; Sundberg JP
    Breast Cancer Res; 2004; 6(6):R668-79. PubMed ID: 15535849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Generation and comparison of two genetically engineered mouse models of ErbB2/Neu positive-PTEN deficient breast cancer].
    Wang QF; Ding H; Liu BR; Zhang K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):427-33. PubMed ID: 25187457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
    Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression.
    Cuello-Carrión FD; Cayado-Gutiérrez N; Natoli AL; Restall C; Anderson RL; Nadin S; Alvarez-Olmedo D; Castro GN; Gago FE; Fanelli MA; Ciocca DR
    Cell Stress Chaperones; 2013 Sep; 18(5):559-67. PubMed ID: 23397229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.
    Li YJ; Liu G; Xia L; Xiao X; Liu JC; Menezes ME; Das SK; Emdad L; Sarkar D; Fisher PB; Archer MC; Zacksenhaus E; Ben-David Y
    Oncotarget; 2015 Nov; 6(35):36943-54. PubMed ID: 26460950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC; Springs AE; Chen WY
    Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effect of alpha-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice.
    Costarelli L; Malavolta M; Giacconi R; Cipriano C; Gasparini N; Tesei S; Pierpaoli S; Orlando F; Suzuki H; Perbellini L; Piacenza F; Emanuelli M; Mocchegiani E
    Oncol Res; 2010; 18(9):409-18. PubMed ID: 20524399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
    Watanabe K; Fallahi M; Dai X
    Oncogene; 2014 Jan; 33(5):632-42. PubMed ID: 23334328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.
    Chooi KF; Carter DA; Biswas S; Lightman SL; Ho MY; Murphy D
    Cancer Res; 1994 Dec; 54(24):6434-40. PubMed ID: 7987839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
    Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA
    Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer.
    Taneja P; Frazier DP; Kendig RD; Maglic D; Sugiyama T; Kai F; Taneja NK; Inoue K
    Expert Rev Mol Diagn; 2009 Jul; 9(5):423-40. PubMed ID: 19580428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promotion of breast cancer by beta-hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice.
    Wong PS; Matsumura F
    BMC Cancer; 2007 Jul; 7():130. PubMed ID: 17640349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM; Welsh J
    Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.